---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-114315"
form_type: "8-K"
ticker: null
cik: "0001394319"
company_name: "Tracon Pharmaceuticals, Inc."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:17:13.401181+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TRACON fails to achieve quorum for liquidation vote; adjourns special meeting to Nov 12

## Summary
- Special meeting to vote on dissolution had only 294,397 shares present; quorum not met.
- CEO Craig R. Jalbert acquired a single Super-Voting Share for $0.01, with extra votes only on dissolution.
- Bylaws amended: quorum now requires majority of voting power, not majority of outstanding shares.
- Super-Voting Share cannot be transferred without board consent; ranks senior to common on liquidation.
- Adjourned special meeting scheduled for November 12, 2024 to achieve quorum.

## SEC filing metadata
- accession: 0000950170-24-114315
- form_type: 8-K
- cik: 0001394319
- company_name: Tracon Pharmaceuticals, Inc.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/0000950170-24-114315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/tcon-20241011.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-114315
- JSON: https://secwatch.observer/filing/0000950170-24-114315.json
- Plain text: https://secwatch.observer/filing/0000950170-24-114315.txt

## Key facts
- Governance Changes
  Tracon Pharmaceuticals, Inc.: Filed Certificate of Designation of Series A Preferred Stock to establish a super-voting share with specific rights and preferences (effective 2024-10-11).
  - Change: charter amendment
  - Effective: 2024-10-11
  source text: On October 11, 2024, the Company filed a Certificate of Designation of Series A Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/0000950170-24-114315-index.htm
- Governance Changes
  Tracon Pharmaceuticals, Inc.: Amended Article III, Section 8 of the bylaws to allow holders of a majority of voting power (rather than a majority of outstanding shares) to constitute a quorum (effective 2024-10-11).
  - Change: bylaw amendment
  - Effective: 2024-10-11
  source text: On October 11, 2024, the Board approved the amendment of Article III, Section 8 of the Company’s bylaws to enable the holders of a majority of the voting power of, rather than the majority of, the outstanding shares of stock of the Company entitled to vote at a meeting of stockholders to constitute a quorum for the transaction of business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017024114315/0000950170-24-114315-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.